Dr Reddys Laboratories (RDY) Income from Non-Controlling Interests (2009 - 2026)
Dr Reddys Laboratories' Income from Non-Controlling Interests came in at -$918,960 for the quarter ended Jun 30, 2026, compared with -$958,146 a year earlier.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Dr Reddys Laboratories reported Income from Non-Controlling Interests of -$4.34 million; for the year ended Mar 31, 2026, it was -$4 million.
- Going back by year, Income from Non-Controlling Interests was $8.29 million in the year ended Mar 31, 2025.
- The five-year range for quarterly Income from Non-Controlling Interests is -$2.27 million (the quarter ended Dec 31, 2025) to $10.29 million (the quarter ended Sep 30, 2024).
- Business Quant data shows RDY's Income from Non-Controlling Interests at $43,757 (quarter ended Mar 31, 2026), -$2.27 million (quarter ended Dec 31, 2025) and -$1.19 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn | -918,959.97 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -918,959.97 |
| Mar 31, 2026 | 43,756.64 |
| Dec 31, 2025 | -2.27 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -958,146.34 |
| Mar 31, 2025 | -762,170.25 |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | 10.29 Mn |
| Mar 31, 2018 | 46.97 Mn |
| Dec 31, 2017 | 51.67 Mn |
| Sep 30, 2017 | 44.33 Mn |
| Dec 31, 2016 | 69.77 Mn |
| Sep 30, 2016 | 44.07 Mn |
| Dec 31, 2013 | -16,124.88 |
| Sep 30, 2013 | -16,126.93 |
| Jun 30, 2013 | -17,972.06 |
| Mar 31, 2013 | -204.26 Mn |
| Dec 31, 2012 | 69.90 Mn |
| Sep 30, 2012 | 71.13 Mn |
| Mar 31, 2012 | 68.13 Mn |
API Access
Dr Reddys Laboratories Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();